Patients Coming Off Weight-Loss Jabs Put On Pounds Far More Rapidly Than Those on Conventional Diets

Fresh analysis reveals that individuals who discontinue new weight-loss injections like Mounjaro or Wegovy may regain lost weight at a significantly accelerated pace than those who halt traditional lifestyle regimens.

Findings released in a major medical journal points out that while obese people frequently drop about a fifth of their total mass while on the medication, the weight is regained at an estimated rate of nearly a kilo each month upon discontinuation.

"People buying such drugs need to be informed of the risk of quick rebound weight gain when the medication concludes," warns expert Dr. Susan Jebb.

Such speed of recovery suggests a return to original weight within about a year and a half.

Analyzing Approaches

The analysis, which looked at 37 of studies involving thousands of patients, contrasted the effects of the injectable medications with conventional dieting.

Researchers point out that individuals who lose weight through lifestyle changes alone typically see a slower creep back—perhaps 0.1 kg a month—once they finish.

Explaining the Rapid Rebound

Experts believe the mode of action of the drugs explains the accelerated regain.

These medications copy a natural hormone called glucagon-like peptide-1, which moderates appetite.

"Sustained high doses of the hormone concentrations far above than normal could lead to the system to produce less of its own natural hormone, and may also diminish sensitivity to its actions," said Dr. Adam Collins, a nutrition specialist.

"Stopping of this hormone supplement leads to hunger is no longer kept in check, making binge eating far more likely."

A Lifelong Issue?

Medical guidelines recommend the injections for individuals with weight-linked health risks, alongside recommended diet and exercise modifications.

A number of clinicians say that, given the high risk of relapse, the treatment might need to be long-term.

This view is echoed by drug manufacturers, who state that the findings "underscore the chronic nature of excess weight," similar to managing conditions like hypertension.

Patient Testimonies

Individuals who have discontinued the jabs explain a intense return of appetite.

"It was like a trigger activating and you're instantly ravenous," said one woman.

The struggle is compounded if users have not adopted sustainable dietary or behavioural changes during therapy.

Significant Interest

Figures indicate that millions of people in the UK have used weight-loss jabs in the last 12 months, with desire remaining high.

• Use is more common among females than men.
• The middle-aged age group shows the highest level of interest.
• A large proportion obtain the medications through private prescriptions rather than the NHS.

In conclusion, clinicians caution that while GLP-1 drugs are powerful tools for weight loss, they are not a magic cure and lasting health benefits hinges on integrated behavioural changes.